Levetiracetam Bluefish

Levetiracetam, the active ingredient in Levetiracetam Bluefish, is an anticonvulsant presented as an oral dosage form for oral use. It is indicated for the treatment of partial seizures, generalized tonic‑clonic seizures and myoclonic seizures in patients diagnosed with epilepsy, helping to reduce seizure frequency and improve neurological stability.

GNH USA supplies Levetiracetam Bluefish as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic medication that targets seizure activity across several seizure types.

- Partial seizures: reduces the frequency and severity of focal onset seizures. - Generalized tonic‑clonic seizures: helps control convulsive episodes in generalized epilepsy. - Myoclonic seizures: diminishes rapid muscle jerks associated with myoclonic epilepsy.

Levetiracetam may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Fatigue: feeling unusually tired or lacking energy. - Headache: mild to moderate cranial pain. - Irritability: increased mood lability or agitation. - Nausea: upset stomach or urge to vomit. - Somnolence: excessive sleepiness during daytime.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Stevens‑Johnson syndrome: serious skin blistering and mucosal involvement. - Mood or behavioral changes: depression, suicidal thoughts, or aggression. - Hematologic abnormalities: low blood cell counts such as neutropenia. - Hepatic dysfunction: elevated liver enzymes or jaundice.

When prescribing levetiracetam, clinicians should consider several safety precautions to optimize patient outcomes. - Renal impairment: adjust dose in patients with reduced kidney function. - Pregnancy: use only if benefit outweighs risk; category B. - Concomitant CNS depressants: monitor for additive sedation. - Psychiatric history: observe for mood changes or aggression. - Discontinuation: taper gradually to avoid seizure exacerbation. - Store at ambient temperature: keep below 25 °C in original container, protect from moisture and light.

Levetiracetam can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: can lower levetiracetam exposure. - Phenytoin: may decrease levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Alcohol: enhances central nervous system depression. - Sedative antihistamines: may increase drowsiness. - Opioids: potential additive sedation. - Other antiepileptics (e.g., valproate): monitor for altered seizure control.